BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Decesaris CM, Mccarroll R, Mishra MV, Glass E, Greenwald BD, Carr S, Burrows W, Mehra R, Regine WF, Simone CB, Choi JI, Molitoris JK. Assessing Outcomes of Patients Treated With Re-Irradiation Utilizing Proton Pencil-Beam Scanning for Primary or Recurrent Malignancies of the Esophagus and Gastroesophageal Junction. Journal of Thoracic Oncology 2020;15:1054-64. [DOI: 10.1016/j.jtho.2020.01.024] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Chuong MD, Hallemeier CL, Li H, Zhu XR, Zhang X, Tryggestad EJ, Yu J, Yang M, Choi JI, Kang M, Liu W, Knopf A, Meijers A, Molitoris JK, Apisarnthanarax S, Giap H, Hoppe BS, Lee P, Chang JY, Simone CB, Lin SH. Executive Summary of Clinical and Technical Guidelines for Esophageal Cancer Proton Beam Therapy From the Particle Therapy Co-Operative Group Thoracic and Gastrointestinal Subcommittees. Front Oncol 2021;11:748331. [PMID: 34737959 DOI: 10.3389/fonc.2021.748331] [Reference Citation Analysis]
2 Wang X, Hobbs B, Gandhi SJ, Muijs CT, Langendijk JA, Lin SH. Current status and application of proton therapy for esophageal cancer. Radiother Oncol 2021;164:27-36. [PMID: 34534613 DOI: 10.1016/j.radonc.2021.09.004] [Reference Citation Analysis]
3 Créhange G, Goudjil F, Krhili SL, Minsat M, de Marzi L, Dendale R. [The role of proton therapy in esophageal cancer]. Cancer Radiother 2021:S1278-3218(21)00248-1. [PMID: 34688549 DOI: 10.1016/j.canrad.2021.08.015] [Reference Citation Analysis]
4 Choi JI, Khan AJ, Powell SN, McCormick B, Lozano AJ, Del Rosario G, Mamary J, Liu H, Fox P, Gillespie E, Braunstein LZ, Mah D, Cahlon O. Proton reirradiation for recurrent or new primary breast cancer in the setting of prior breast irradiation. Radiother Oncol 2021;165:142-51. [PMID: 34688807 DOI: 10.1016/j.radonc.2021.10.010] [Reference Citation Analysis]
5 Patel NV, Yu NY, Koroulakis A, Diwanji T, Sawant A, Sio TT, Mohindra P. Proton therapy for thoracic malignancies: a review of oncologic outcomes. Expert Rev Anticancer Ther 2021;21:177-91. [PMID: 33118427 DOI: 10.1080/14737140.2021.1844567] [Reference Citation Analysis]
6 Simone CB 2nd. First Randomized Trial Supporting the Use of Proton Over Photon Chemoradiotherapy in Esophageal Cancer. J Clin Oncol 2020;38:2952-5. [PMID: 32706638 DOI: 10.1200/JCO.20.01405] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
7 Beddok A, Calugaru V, de Marzi L, Graff P, Dumas JL, Goudjil F, Dendale R, Minsat M, Verrelle P, Buvat I, Créhange G. Clinical and technical challenges of cancer reirradiation: Words of wisdom. Crit Rev Oncol Hematol 2022;:103655. [PMID: 35398521 DOI: 10.1016/j.critrevonc.2022.103655] [Reference Citation Analysis]
8 Doyen J, Aloi D, Groulier A, Vidal M, Lesueur P, Calugaru V, Bondiau PY. Role of proton therapy in reirradiation and in the treatment of sarcomas. Cancer Radiother 2021:S1278-3218(21)00123-2. [PMID: 34284969 DOI: 10.1016/j.canrad.2021.06.024] [Reference Citation Analysis]